
Botulinum Toxin for the Treatment of Hyperfunctional Lines of the Face
Andrew Blitzer, MD, DDS;
Mitchell F. Brin, MD;
Monte S. Keen, MD;
Jonathan E. Aviv, MD
Arch Otolaryngol Head Neck Surg. 1993;119(9):1018-1022.
Abstract
 |  |
Objective To determine the effectiveness of botulinum toxin injections for the management of hyperfunctional facial lines in patients with dystonia.
Design Twenty-six patients were included in the study: 24 patients had dystonic movement of the face as either a primary or secondary component, and two patients were treated for purely hyperfunctional lines. Botulinum toxin type A was injected via a monopolar hollow-bore Tefloncoated electromyography needle into the facial muscles associated with the hyperfunctional lines. Doses were divided into 1.25- to 10-U aliquots. Qualitative assessments by the patient and physician were made before injection and 2 to 3 weeks after injection.
Patients Twenty-six patients (two male and 24 female) with hyperfunctional lines were included. The ages were from 32 to 84 years with an average age of 59 years. Twenty had dystonia, four had hemifacial spasm, and two had pure hyperfunction without neuromuscular disease.
Results All of the patients had an effect of toxin within the first 24 to 72 hours. All of the patients experienced benefit from the toxin injections with partial or total resolution of painful contractions or unsightly hyperfunctional lines and spasms. The effects of the injection lasted 3 to 6 months. No systemic side effects were noted. Adverse effects included mild, temporary eyelid or lip weakness.
Conclusion Based on this initial pilot study, botulinum toxin may be an important new option for the treatment of patients with hyperfunctional facial lines.
(Arch Otolaryngol Head Neck Surg. 1993;119:1018-1022)
Author Affiliations
From the Departments of Otolaryngology (Drs Blitzer, Keen, and Aviv) and Neurology (Dr Brin) and the Dystonia Clinical Research Center, Columbia-Presbyterian Medical Center, New York, NY.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Detection and Quantification of Botulinum Neurotoxin Type A by a Novel Rapid In Vitro Fluorimetric Assay
Poras et al.
Appl. Environ. Microbiol. 2009;75:4382-4390.
ABSTRACT
| FULL TEXT
Lasers and Optical Technologies in Facial Plastic Surgery
Wu and Wong
Arch Facial Plast Surg 2008;10:381-390.
ABSTRACT
| FULL TEXT
A Validated Rating Scale for Hyperkinetic Facial Lines
Kim et al.
Arch Facial Plast Surg 2004;6:253-256.
ABSTRACT
| FULL TEXT
Cosmetic Uses of Botulinum Neurotoxin Type A: An Overview
Blitzer and Binder
Arch Facial Plast Surg 2002;4:214-220.
FULL TEXT
Effect of Botulinum Toxin Pretreatment on Laser Resurfacing Results: A Prospective, Randomized, Blinded Trial
Zimbler et al.
Arch Facial Plast Surg 2001;3:165-169.
ABSTRACT
| FULL TEXT
Radiofrequency Ablation of the Nerve to the Corrugator Muscle for Elimination of Glabellar Furrowing
Utley and Goode
Arch Facial Plast Surg 1999;1:46-48.
ABSTRACT
| FULL TEXT
An Anatomical Approach to Glabellar Rhytids
Macdonald et al.
Arch Otolaryngol Head Neck Surg 1998;124:1315-1320.
ABSTRACT
| FULL TEXT
Chemical Browlift
Frankel and Kamer
Arch Otolaryngol Head Neck Surg 1998;124:321-323.
ABSTRACT
| FULL TEXT
Patient Selection in the Treatment of Glabellar Wrinkles With Botulinum Toxin Type A Injection
Pribitkin et al.
Arch Otolaryngol Head Neck Surg 1997;123:321-326.
ABSTRACT
Botulinum Toxin
Carruthers and Carruthers
Arch Otolaryngol Head Neck Surg 1995;121:704-704.
ABSTRACT
Botulinum Toxin-Reply
Blitzer and Brin
Arch Otolaryngol Head Neck Surg 1995;121:704-704.
ABSTRACT
|